Satya Nadella testifies in Musk v. Altman trial

Microsoft CEO Satya Nadella took the witness stand on May 11 in the federal Musk v. Altman trial in Oakland, California, testifying about Microsofts early partnership with OpenAI, according to CNBC. Elon Musk named Microsoft as a defendant in his lawsuit against OpenAI and its CEO Sam Altman, alleging that Microsoft aided and abetted an alleged breach of charitable trust, CNBC reports. The litigation seeks large damages; The New York Times reports Musk is pursuing as much as $150 billion. CNBC and other coverage note Microsofts investments in OpenAI described as more than $13 billion across multiple deals have been a focal point of testimony. Musk testified that Microsofts $10 billion investment made him believe OpenAI was violating its nonprofit mission, CNBC reports.
What happened
Satya Nadella took the witness stand on May 11 in the federal Musk v. Altman trial in Oakland, California, testifying about his role at Microsoft and the companys early strategic partnership with OpenAI, CNBC reports. According to CNBC, Elon Musk named Microsoft as a defendant in his lawsuit against OpenAI and its CEO Sam Altman, accusing Microsoft of aiding and abetting an alleged breach of charitable trust. The New York Times reports Musk is seeking as much as $150 billion in damages. CNBC notes that Microsofts cumulative investments in OpenAI, described in coverage as more than $13 billion across deals in 2019, 2021, and 2023, were repeatedly discussed during testimony. CNBC also quotes Musk from the stand: "I was concerned they were really trying to steal the charity."
Editorial analysis - technical context
Industry-pattern observations: Large corporate investments and commercial partnerships with research-focused organizations typically surface archived emails, discounted-service agreements, and governance documents during litigation. Reporting from AFP, CNBC, and Technology Review highlights that internal Microsoft emails about discounted Azure access and early investment negotiations have been introduced as evidence. For practitioners, these document types commonly clarify commercial terms, cost structures, and timelines that courts use to assess claims about mission drift and contractual obligations.
Context and significance
Reporting by The New York Times and Technology Review frames the Musk v. Altman trial as a test case for how nonprofit-origin governance and commercial investment interact in frontier-technology firms. Technology Review and other outlets describe testimony from OpenAI cofounders, including Greg Brockman, and disclosures that Elon Musk pressed for a for-profit arm in earlier discussions. Observers following the sector have noted that an adverse legal outcome could create precedent around donor expectations, conversion mechanics, and investor liability when a nonprofit-backed project adopts venture funding.
What to watch
Editorial analysis: Observers will watch for:
- •how the court interprets archived communications and board decisions introduced by both parties
- •whether the jury assigns liability to investors versus company leaders
- •any judicial findings about fiduciary duties tied to nonprofit-origin commitments. Reporting will also track subsequent testimony from OpenAI executives, including Sam Altman and Greg Brockman, and any further Microsoft witnesses or documentary evidence about the 2019, 2021, and 2023 investments that CNBC and AFP cited
Additional reported details
CNBC and AFP coverage note that Microsoft has been a partner and investor in OpenAI since 2019, with multibillion-dollar commitments and commercial cloud arrangements that figure centrally in the dispute. Technology Review and The New York Times provide courtroom color and background on prior testimony from Musk, Brockman, and other former OpenAI employees that the jury has heard in earlier weeks.
For practitioners
Editorial analysis: Legal scrutiny of governance transitions from nonprofit research labs to venture-funded entities illustrates a recurring operational risk for teams building dual-purpose research and commercial organizations. Practitioners structuring partnerships between research groups and strategic investors should expect heightened attention to documented donor communications, service discounts, and formal governance amendments in environments where mission statements and commercial incentives diverge.
Scoring Rationale
The trial directly concerns corporate governance, investor liability, and nonprofit-to-profit conversions in a leading AI company, topics that materially affect practitioners who structure partnerships, funding, and governance for AI research organizations.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
